Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|August 13, 2014
Proteus genomic island 1 (PGI1), a new resistance genomic island from two Proteus mirabilis French clinical isolatesEliane Siebor, Catherine Neuwirth
International Journal of Antimicrobial Agents|August 4, 2020
New insights regarding Acinetobacter genomic island-related elementsEliane Siebor, Catherine Neuwirth
The Journal of Antimicrobial Chemotherapy|April 13, 2013
Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, FranceEliane Siebor, Catherine Neuwirth
The Journal of Antimicrobial Chemotherapy|November 10, 2018
Identification of AGI1-A, a variant of Acinetobacter genomic island 1 (AGI1), in a French clinical isolate belonging to the Enterobacter cloacae complexEliane Siebor, Claire de Curraize, Catherine Neuwirth
The Journal of Antimicrobial Chemotherapy|April 19, 2018
Genomic context of resistance genes within a French clinical MDR Proteus mirabilis: identification of the novel genomic resistance island GIPmi1Eliane Siebor, Claire de Curraize, Catherine Neuwirth
Antimicrobial Agents and Chemotherapy|October 17, 2007
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from FranceCatherine Neuwirth, Eliane Siebor, Frederic Robin, et al.
Antimicrobial Agents and Chemotherapy|October 24, 2012
Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pumpJulien Bador, Lucie Amoureux, Emmanuel Blanc, et al.
Pageof 6